Comprehensive Overview of global Initiatives on Medicine Regulation published
Recommendation

17/18 June 2026
Copenhagen, Denmark
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
The European Medicines Agency (EMA) has published an overview of existing international regulatory initiatives for human medicines, like for example International Council for Harmonisation (ICH), Pharmaceutical Inspection Co-operation Scheme (PIC/S), International Pharmaceutical Regulators Forum (IPRF) and International Coalition of Medicines Regulatory Authorities (ICMRA) members.
The report entitled "Connecting the dots - Towards global knowledge of the international medicine regulatory landscape: mapping of international initiatives" also lists the respective international projects and details on the number and scope of global initiatives.
The aim of the mapping exercise is to raise awareness of ongoing international regulatory activities, help establish a basis for a more strategic coordination to avoid duplication of efforts, and identify possible gaps.
In the conclusion, EMA mentions that there is "a myriad of initiatives but no strategic coordination". So these mappings and analyses should "strongly support the need for a global strategy to support cooperation between international medicines regulators, to help avoid an overlap of activities and make resources available for areas where gaps still exist."
Related GMP News
29.05.2026European QP Association Developments January through April 2026
15.04.2026ICH Q9 Training Package updated
01.04.2026New EMA GMP Guidelines in the next three Years
01.04.2026New EMA Guidance: Risk Management for Elemental Impurities in Veterinary Medicinal Products
18.03.2026Sampling in the Focus of the FDA
11.03.2026EU Pharma Package: Final Texts officially published


